Creative Financial Designs Inc Abb Vie Inc. Transaction History

Creative Financial Designs Inc

$1.16 Billion
Q3 2024

A detailed history of Creative Financial Designs Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Creative Financial Designs Inc holds 2,422 shares of ABBV stock, worth $435,960. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,422

Previous 2,532 4.34%

Holding current value

$435,960

Previous $434,000 10.14%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $18,022 - $21,926	-110 Reduced 4.34%	2,422 $478,000
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $3,250 - $3,795	-21 Reduced 0.82%	2,532 $434,000
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $54,978 - $62,642	-344 Reduced 11.87%	2,553 $464,000
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $5,779 - $6,508	-42 Reduced 1.43%	2,897 $448,000
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $23,779 - $27,527	-178 Reduced 5.71%	2,939 $438,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $35,645 - $44,358	-269 Reduced 7.94%	3,117 $419,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $133,475 - $153,716	-923 Reduced 21.42%	3,386 $539,000
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $80,358 - $96,370	-581 Reduced 11.88%	4,309 $696,000
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $47,241 - $54,183	-352 Reduced 6.71%	4,890 $656,000
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $93,856 - $119,322	-682 Reduced 11.51%	5,242 $803,000
Q1 2022 Apr 15, 2022	SELL	$131.98 - $163.75 $20,060 - $24,890	-152 Reduced 2.5%	5,924 $960,000
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $32,551 - $41,186	303 Added 5.25%	6,076 $823,000
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $5,320 - $6,039	50 Added 0.87%	5,773 $623,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $72,805 - $81,109	692 Added 13.75%	5,723 $645,000
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $36,111 - $39,754	353 Added 7.55%	5,031 $544,000
Q4 2020 Jan 08, 2021	BUY	$80.49 - $108.67 $270,043 - $364,587	3,355 Added 253.59%	4,678 $501,000
Q3 2020 Oct 06, 2020	BUY	$85.91 - $100.83 $96,734 - $113,534	1,126 Added 571.57%	1,323 $116,000
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $6,163 - $8,247	84 Added 74.34%	197 $19,000
Q1 2020 Apr 22, 2020	BUY	$64.5 - $97.79 $6,901 - $10,463	107 Added 1783.33%	113 $9,000
Q2 2018 Jul 13, 2018	SELL	$89.78 - $106.23 $38,336 - $45,360	-427 Reduced 98.61%	6 $1,000
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $3,036 - $4,065	33 Added 8.25%	433 $41,000
Q4 2017 May 02, 2018	BUY	$89.56 - $98.21 $35,824 - $39,284	400 New	400 $39,000
Q1 2017 May 02, 2018	SELL	N/A	-450 Closed	0 $0
Q4 2016 Mar 14, 2018	BUY	N/A	450	450 $28,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Account

Creative Financial Designs Inc Abb Vie Inc. Transaction History